| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Edward K. Russell | SVP, Business Development | $457K | Jan 16, 2022 | ||
| Charles P. Slacik | Director | $379K | Jan 25, 2022 | ||
| Randall J. Steward | Chief Financial Officer | $360K | Feb 3, 2022 | ||
| Kathy Ordonez | Director | $45.6K | May 18, 2021 | ||
| Widder Kenneth J | Director | May 27, 2022 | |||
| Kenneth F. Buechler | Director | May 27, 2022 | |||
| Ann D. Rhoads | Director | May 27, 2022 | |||
| Michelle A. Hodges | SVP, General Counsel | May 27, 2022 | |||
| Robert J. Bujarski | Chief Operating Officer | May 27, 2022 | |||
| Joseph D. Wilkins Jr. | Director | May 27, 2022 | |||
| William J. Ferenczy | SVP, Cardio/Metabolic Unit | May 27, 2022 | |||
| Tamara A. Ranalli | SVP, Molecular Bus. Unit | May 27, 2022 | |||
| Mary Lake Polan | Director | May 27, 2022 | |||
| Werner Kroll | Svp, R&D | May 27, 2022 | |||
| Matthew Strobeck | Director | May 27, 2022 | |||
| Edward L. Michael | Director | May 27, 2022 | |||
| Douglas C. Bryant | President & CEO, Director | May 27, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|